Market Overview:
The global canine flu therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of canine flu, rising demand for better and advanced therapies, and growing awareness about preventive measures against canine flu. The global canine flu therapeutics market is segmented on the basis of type into vaccines and others. The vaccines segment is further sub-segmented into inactivated vaccine and live attenuated vaccine. On the basis of application, the market is segmented into vet clinics, veterinary hospitals, animal healthcare facilities, research institutes & universities, and others. Geographically, the global Canine Flu Therapeutics Market is divided into North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia New Zealand) Middle East & Africa (GCC Countries Turkey Nigeria South Africa).
Product Definition:
Canine flu therapeutics is a term used to describe the use of medications and therapies used to treat canine influenza. The importance of canine flu therapeutics is that it can help reduce the symptoms of the disease and speed up the recovery process.
Vaccines:
Vaccines are biological agents used to stimulate the body's immune system to act against an infectious disease. The diseases for which vaccines are developed include polio, measles, mumps, chickenpox, influenza (flu), hepatitis A & B and human papillomavirus (HPV). Flu is one of the most common contagious diseases experienced throughout the world.
Others:
Others include vaccines, antivirals, immunomodulators and immune-stimulating agents. The others segment is expected to grow at a lucrative rate during the forecast period owing to its increased usage in the treatment of canine flu therapeutics market.
The global canine flu therapeutics market was valued over USD 1 billion in 2014.
Application Insights:
Based on application, the global canine flu therapeutics market is segmented into vet clinics, veterinary hospitals and animal healthcare facilities. The vet clinics segment held the largest share in 2017 due to presence of a large number of veterinary hospitals and animal healthcare facilities. This is also supported by high usage rates of dogs for hunting purposes which increases susceptibility to respiratory diseases.
The Veterinary Hospitals (VH) application segment is expected to grow at a lucrative rate during the forecast period owing to rising awareness among practitioners regarding treatment protocols for H3N2-infected canines along with availability of advanced diagnostics tools such as real-time PCR that aids in early detection and rapid response during an outbreak. Furthermore, VHs are equipped with state-of-the art equipment that allows rapid testing for both viral & bacterial infections which further supports growth during an outbreak scenario.
Regional Analysis:
North America dominated the global canine flu therapeutics market in 2017. This is due to high pet adoption coupled with a favorable healthcare system for animals. Moreover, increasing veterinary hospital construction and expansion activities are also expected to drive the demand for veterinary drugs in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income of consumers and their pets, improving animal health services along with growing awareness about vaccination programs among pet owners. Furthermore, China has been one of the worst hit countries by this outbreak as it had more than 1 million cases reported within six months after it began which was unprecedented worldwide until now (late August). The country has since then developed several vaccines against different strains of canine influenza virus A & B but still faces an enormous challenge in controlling this highly contagious disease across all its provinces especially during winter season when dogs get infected most easily from other dogs or from human contact through coughing or sneezing etc.
Growth Factors:
- Increasing incidence of canine flu across the globe
- Growing awareness about the benefits of canine flu therapy among pet owners
- Rising demand for innovative and effective veterinary therapies
- Availability of government funding for research on canine flu therapies
- Technological advancements in the field of veterinary therapeutics
Scope Of The Report
Report Attributes
Report Details
Report Title
Canine Flu Therapeutics Market Research Report
By Type
Vaccines, Others
By Application
Vet Clinics, Veterinary Hospitals, Animal Healthcare Facilities
By Companies
Merck & Co, Intervet, Zoetis Services
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Canine Flu Therapeutics Market Report Segments:
The global Canine Flu Therapeutics market is segmented on the basis of:
Types
Vaccines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vet Clinics, Veterinary Hospitals, Animal Healthcare Facilities
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co
- Intervet
- Zoetis Services
Highlights of The Canine Flu Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaccines
- Others
- By Application:
- Vet Clinics
- Veterinary Hospitals
- Animal Healthcare Facilities
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Canine Flu Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Canine Flu Therapeutics is a veterinary pharmaceutical company that develops and manufactures products to treat canine influenza. The company's products include antiviral drugs, vaccines, and diagnostic tests.
Some of the major players in the canine flu therapeutics market are Merck & Co, Intervet, Zoetis Services.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Canine Flu Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Canine Flu Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Canine Flu Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Canine Flu Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Canine Flu Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Canine Flu Therapeutics Market Size and Y-o-Y Growth
4.5.2 Canine Flu Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Vaccines
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Vet Clinics
6.2.2 Veterinary Hospitals
6.2.3 Animal Healthcare Facilities
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Canine Flu Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Canine Flu Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Vaccines
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Vet Clinics
9.10.2 Veterinary Hospitals
9.10.3 Animal Healthcare Facilities
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Vaccines
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Vet Clinics
10.10.2 Veterinary Hospitals
10.10.3 Animal Healthcare Facilities
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Vaccines
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Vet Clinics
11.10.2 Veterinary Hospitals
11.10.3 Animal Healthcare Facilities
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Vaccines
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Vet Clinics
12.10.2 Veterinary Hospitals
12.10.3 Animal Healthcare Facilities
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Vaccines
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Vet Clinics
13.10.2 Veterinary Hospitals
13.10.3 Animal Healthcare Facilities
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Canine Flu Therapeutics Market: Competitive Dashboard
14.2 Global Canine Flu Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co
14.3.2 Intervet
14.3.3 Zoetis Services
